Solmaz İhsan, Araç Songül
Department of Internal Medicine, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey.
Department of Emergency Medicine, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey.
Int J Clin Pract. 2021 Apr;75(4):e13927. doi: 10.1111/ijcp.13927. Epub 2020 Dec 19.
The aim of this study was to investigate the ABO and Rh blood group distribution and clinical characteristics in patients with COVID-19.
The clinical characteristics and blood groups of 1667 patients who were hospitalised because of COVID-19 (with a positive PCR test) between 16 March and 10 July were reviewed cross-sectionally.
When blood groups of patients diagnosed with COVID-19 and control group were compared, it was observed that there was an increase in the number of COVID-19 patients with blood groups A and AB, decrease in the number of COVID-19 patients with blood group O, a statistically significant increase in the number of individuals with blood group A in COVID-19 patients compared with healthy individuals, and almost significant increase in the number of COVID-19 patients with blood group AB and a very significant decrease in the number of COVID-19 patients with blood group O.
Our study has found that having blood group O may be protective, that blood group A may have greater susceptibility to the disease, but this does not affect the course of the disease and is not associated with mortality.
本研究旨在调查新型冠状病毒肺炎(COVID-19)患者的ABO和Rh血型分布及临床特征。
对3月16日至7月10日期间因COVID-19住院(聚合酶链反应检测呈阳性)的1667例患者的临床特征和血型进行横断面回顾。
将COVID-19确诊患者的血型与对照组进行比较时,发现COVID-19患者中A型和AB型血的人数增加,O型血的COVID-19患者人数减少;与健康个体相比,COVID-19患者中A型血个体数量有统计学意义的增加,AB型血的COVID-19患者数量几乎有显著增加,O型血的COVID-19患者数量有非常显著的减少。
我们的研究发现,O型血可能具有保护作用,A型血可能对该疾病更易感,但这并不影响疾病进程,也与死亡率无关。